Skip to main content
Top

Journal of Bone and Mineral Metabolism

Issue 1/2002

Content (8 Articles)

Importance of deletion of T at nucleotide 1559 in the tissue-nonspecific alkaline phosphatase gene in Japanese patients with hypophosphatasia

Hideo Orimo, Masae Goseki-Sone, Mitsuko Inoue, Yuriko Tsubakio, Takeshi Sakiyama, Takashi Shimada

Altered bone turnover in chlorpromazine-challenged rats and its effect on 1α-hydroxyvitamin D3 administration in vivo

Koutaro Oh-ie, Takashi Miyazaki, Iwao Koyama, Shigeru Hokari, Tsugikazu Komoda

Bone ultrasonometry, bone density, and turnover markers in type 1 Gaucher disease

Carmelo Erio Fiore, Rita Barone, Pietra Pennisi, Vito Pavone, Stefania Riccobene

The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin

Ali Gür, Leyla Çolpan, Kemal Nas, Remzi Çevik, Jale Saraç, Ferda Erdoğan, M. Zahir Düz

Comparison of the effects of transdermal estrogen, oral estrogen, and oral estrogen-progestogen therapy on bone mineral density in postmenopausal women

Mehmet B. Çetinkaya, Arif Kökçü, Filiz F. Yanik, Tarik Başoğlu, Erdal Malatyalioglu, Tayfun Alper

Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up

Sulin Cheng, Harri Suominen, Kalervo Väänänen, Sanna-Maria Käkönen, Kim Pettersson, Eino Heikkinen

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine